Lower urinary tract symptoms: What are the implications for the patients?

European Urology

Volumn 40, Issue SUPPL. 4, 2001, Pages 12-20

  Scarpa, Roberto M ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bother; BPH; Disease management; Europe; Italy; LUTS; Quality of Life; Sexuality; UK

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALFUZOSIN; ALPHA 1A ADRENERGIC RECEPTOR; DOXAZOSIN; FINASTERIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; TAMSULOSIN; TERAZOSIN;

CLINICAL PRACTICE; CONFERENCE PAPER; DAILY LIFE ACTIVITY; EJACULATION; HUMAN; LIFESTYLE; MICTURITION; MICTURITION DISORDER; NOCTURIA; PENIS ERECTION; PHYTOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SEXUAL BEHAVIOR; SEXUALITY; SYMPTOM; TRANSURETHRAL RESECTION; URINARY DYSFUNCTION; URINE INCONTINENCE;

ADRENERGIC ALPHA-ANTAGONISTS; DATA COLLECTION; EUROPE; FINASTERIDE; HUMANS; LIFE STYLE; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PENILE ERECTION; PREVALENCE; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; SULFONAMIDES; URINARY RETENTION;

EID: 0035688837     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049890     Document Type: Conference Paper

References (29)

1. High prevalence of benign prostatic hypertrophy in the community
2. The progression of benign prostatic hypeplasia: Examining the evidence and determining the risk
3. Quality-of-life aspects in urology - Benign prostatic hyperplasia
4. The International Continence Society 'Benign Prostatic Hyperplasia' study: The bothersomeness of urinary symptoms
5. Urinary symptoms in the community: How bothersome are they?
6. Introduction
7. The American Urological Association symptom index for benign prostatic hyperplasia
8. International Continence Society 'Benign Prostatic Hyperplasia' Study: Background, aims, and methodology
9. Community study of uncomplicated lower urinary tract symptoms among male Italian immigrants in Sydney, Australia
10. Implications of the most bothersome prostatism symptom for clinical care and outcomes research
11. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community
12. A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia
13. Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men
14. Tamsulosin 0.4 mg once daily: Effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction
15. Sexual function in patients with symptomatic benign prostatic hyperplasia
16. Determinants of treatment-seeking behaviour for urinary symptoms in older men
17. Introduction and concluding remarks
18. Lower urinary tract symptoms suggestive of benign prostatic obstruction: What are the current practice patterns?
19. Management of symptomatic BPH in Italy: Who is treated and how?
20. 1-adrenoceptor subtype-specific blockade
21. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
22. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia
23. Results of the PREDICT (Prospective European Doxazosin and Combination Therapy) trial
24. 1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction
25. 1-Blockers for BPH: Are there differences?
26. Open prostatectomy in benign prostatic hyperplasia: 10-Year experience in Italy
27. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials